E-LIB Suche - Ergebnisse für: Goberna, R.

1

Leptin promotes cell survival and activates Jurkat T lympho..:

Fernández-Riejos, P ; Goberna, R ; Sánchez-Margalet, V
Clinical and Experimental Immunology. 151 (2008) 3 - p. 505-518 , 2008

Link: https://doi.org/10.1111/..

2

Sam68 is tyrosine phosphorylated and recruited to signallin..:

Najib, S ; Rodríguez-Baño, J ; Ríos, M J...
Clinical and Experimental Immunology. 141 (2005) 3 - p. 518-525 , 2005

Link: https://doi.org/10.1111/..

3

Leptin stimulates the oxidative burst in control monocytes ..:

SÁNCHEZ-POZO, C ; RODRIGUEZ-BAÑO, J ; DOMÍNGUEZ-CASTELLANO, A...
Clinical and Experimental Immunology. 134 (2003) 3 - p. 464-469 , 2003

Link: https://doi.org/10.1111/..

4

Role of leptin as an immunomodulator of blood mononuclear c..:

SÁNCHEZ-MARGALET, V ; MARTÍN-ROMERO, C ; SANTOS-ALVAREZ, J...
Clinical and Experimental Immunology. 133 (2003) 1 - p. 11-19 , 2003

Link: https://doi.org/10.1046/..

5

Leptin receptor (Ob-R) expression is induced in peripheral ..:

SÁNCHEZ-MARGALET, V ; MARTÍN-ROMERO, C ; GONZÁLEZ-YANES, C...
Clinical and Experimental Immunology. 129 (2002) 1 - p. 119-124 , 2002

Link: https://doi.org/10.1046/..

6

Pancreastatin inhibits insulin-stimulated glycogen synthesi..:

Sánchez-Margalet, V. ; Goberna, R.
Regulatory Peptides. 51 (1994) 3 - p. 215-220 , 1994

Link: https://doi.org/10.1016/..

7

Pancreastatin (33–49) enhances the priming effect of glucos..:

Sánchez-Margalet, V. ; Goberna, R.
Experientia. 49 (1993) 6-7 - p. 551-552 , 1993

Link: https://doi.org/10.1007/..

8

Pancreastatin decreases plasma epinephrine levels in surgic..:

Sánchez-Margalet, V. ; Goberna, R.
Peptides. 14 (1993) 4 - p. 797-799 , 1993

Link: https://doi.org/10.1016/..

9

Stimulatory effect of vasoactive intestinal peptide (VIP) o..:

Segura, J.J. ; Guerrero, J.M. ; Goberna, R..
Regulatory Peptides. 37 (1992) 3 - p. 195-203 , 1992

Link: https://doi.org/10.1016/..

10

Chronic ethanol intake inhibits both the vasoactive intesti..:

Jimenez, J. ; Calvo, J.R. ; Molinero, P...
General Pharmacology: The Vascular System. 23 (1992) 4 - p. 607-611 , 1992

Link: https://doi.org/10.1016/..

11

Somatostatin inhibition of VIP- and isoproterenol-stimulate..:

Segura, J.J. ; Guerrero, J.M. ; Goberna, R..
Neuropeptides. 23 (1992) 1 - p. 39-43 , 1992

Link: https://doi.org/10.1016/..

12

Characterization of functional receptors for vasoactive int..:

Segura, J.J. ; Guerrero, J.M. ; Goberna, R..
Regulatory Peptides. 33 (1991) 2 - p. 133-143 , 1991

Link: https://doi.org/10.1016/..

13

Glycogenolytic effect of vasoactive intestinal peptide in t..:

Sánchez, V. ; Goberna, R. ; Calvo, J. R.
Experientia. 47 (1991) 6 - p. 625-626 , 1991

Link: https://doi.org/10.1007/..

14

Characterization of melatonin binding sites in the Harderia..:

Lopez-Gonzalez, M.A. ; Calvo, J.R. ; Rubio, A...
Life Sciences. 48 (1991) 12 - p. 1165-1171 , 1991

Link: https://doi.org/10.1016/..

15

Ontogeny of type II thyroxine 5′-deiodinase, N-acetyltransf..:

Osuna, C. ; Rubio, A. ; Goberna, R..
Life Sciences. 46 (1990) 26 - p. 1945-1951 , 1990

Link: https://doi.org/10.1016/..